Ngā hua rapu - Luis Ostrosky‐Zeichner

Whakamahine hua
  1. 1
    Invasive Mycoses: Diagnostic Challenges

    Invasive Mycoses: Diagnostic Challenges mā Luis Ostrosky‐Zeichner

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Editorial Commentary: Candida glabrata and FKS Mutations: Witnessing the Emergence of the True Multidrug-Resistant Candida

    Editorial Commentary: Candida glabrata and FKS Mutations: Witnessing the Emergence of the True Multidrug-Resistant Candida mā Luis Ostrosky‐Zeichner

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Editorial
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Isavuconazole: Mechanism of Action, Clinical Efficacy, and Resistance

    Isavuconazole: Mechanism of Action, Clinical Efficacy, and Resistance mā Misti Ellsworth, Luis Ostrosky‐Zeichner

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Fungal Infections in People Who Use Drugs

    Fungal Infections in People Who Use Drugs mā Jesse Gonzales, Luis Ostrosky‐Zeichner

    I whakaputaina 2025
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: approach to developing practical criteria for systematic use in antifungal prophylaxis trials

    Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: approach to developing practical criteria for systematic use in antifu... mā Niki I. Paphitou, Luis Ostrosky‐Zeichner, John Rex

    I whakaputaina 2005
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    New serological markers in medical mycology: (1,3)-(-D-glucan and Aspergillus galactomannan

    New serological markers in medical mycology: (1,3)-(-D-glucan and Aspergillus galactomannan mā Luis Ostrosky‐Zeichner, Roxana G. Vitale, Márcio Nucci

    I whakaputaina 2012
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Antifungal Susceptibility Testing: Current Approaches

    Antifungal Susceptibility Testing: Current Approaches mā Elizabeth L. Berkow, Shawn R. Lockhart, Luis Ostrosky‐Zeichner

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Effects of Serum on In Vitro Susceptibility Testing of Echinocandins

    Effects of Serum on In Vitro Susceptibility Testing of Echinocandins mā Zekaver Odabaşı, Victor L. Paetznick, John Rex, Luis Ostrosky‐Zeichner

    I whakaputaina 2007
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Treatment of candidemia and invasive candidiasis in the intensive care unit: post hoc analysis of a randomized, controlled trial comparing micafungin and liposomal amphotericin B

    Treatment of candidemia and invasive candidiasis in the intensive care unit: post hoc analysis of a randomized, controlled trial comparing micafungin and liposomal amphotericin B mā B. Dupont, Olivier Lortholary, Luis Ostrosky‐Zeichner, Flavie Stucker, Vijay Yeldandi

    I whakaputaina 2009
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    (1,3)- -D-Glucan as a Prognostic Marker of Treatment Response in Invasive Candidiasis

    (1,3)- -D-Glucan as a Prognostic Marker of Treatment Response in Invasive Candidiasis mā Siraya Jaijakul, José A. Vázquez, R. N. Swanson, Luis Ostrosky‐Zeichner

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Development, delivery, and evaluation of the Texas Epidemic Public Health Institute pilot infection control lecture series

    Development, delivery, and evaluation of the Texas Epidemic Public Health Institute pilot infection control lecture series mā Kayla Ruch, Anabel Rodriguez, Janelle Rios, Luis Ostrosky‐Zeichner, Eric L. Brown

    I whakaputaina 2025
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Empirical Antimicrobial Therapy for Traveler's Diarrhea

    Empirical Antimicrobial Therapy for Traveler's Diarrhea mā Javier A. Adachi, Luis Ostrosky‐Zeichner, Herbert L. DuPont, Charles D. Ericsson

    I whakaputaina 2000
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    An insight into the antifungal pipeline: selected new molecules and beyond

    An insight into the antifungal pipeline: selected new molecules and beyond mā Luis Ostrosky‐Zeichner, Arturo Casadevall, John N. Galgiani, Frank C. Odds, John Rex

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    In Vitro Activity of Anidulafungin against Selected Clinically Important Mold Isolates

    In Vitro Activity of Anidulafungin against Selected Clinically Important Mold Isolates mā Zekaver Odabaşı, Victor L. Paetznick, José C. Rodríguez‐Rey, Enuo Chen, Luis Ostrosky‐Zeichner

    I whakaputaina 2004
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Combination Antifungal Therapy

    Combination Antifungal Therapy mā Melissa D. Johnson, Conan MacDougall, Luis Ostrosky‐Zeichner, John R. Perfect, John Rex

    I whakaputaina 2004
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Amphotericin B: Time for a New "Gold Standard"

    Amphotericin B: Time for a New "Gold Standard" mā Louis D. Saravolatz, Luis Ostrosky‐Zeichner, Kieren A. Marr, John Rex, Stuart H. Cohen

    I whakaputaina 2003
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Invasive candidiasis

    Invasive candidiasis mā Peter G. Pappas, Michail S. Lionakis, Maiken Cavling Arendrup, Luis Ostrosky‐Zeichner, Bart Jan Kullberg

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Correlation of Clinical Outcomes with β-Glucan Levels in Patients with Invasive Candidiasis

    Correlation of Clinical Outcomes with β-Glucan Levels in Patients with Invasive Candidiasis mā Charles R. Sims, Siraya Jaijakul, John Mohr, José E. Rodríguez, Malcolm Finkelman, Luis Ostrosky‐Zeichner

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Correlation between E-Test, Disk Diffusion, and Microdilution Methods for Antifungal Susceptibility Testing of Fluconazole and Voriconazole

    Correlation between E-Test, Disk Diffusion, and Microdilution Methods for Antifungal Susceptibility Testing of Fluconazole and Voriconazole mā Madonna Matar, Luis Ostrosky‐Zeichner, Victor L. Paetznick, José C. Rodríguez‐Rey, Enuo Chen, John Rex

    I whakaputaina 2003
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Thinking beyond the Common Candida Species: Need for Species-Level Identification of Candida Due to the Emergence of Multidrug-Resistant Candida auris

    Thinking beyond the Common Candida Species: Need for Species-Level Identification of Candida Due to the Emergence of Multidrug-Resistant Candida auris mā Shawn R. Lockhart, Brendan R. Jackson, Snigdha Vallabhaneni, Luis Ostrosky‐Zeichner, Peter G. Pappas, Tom Chiller

    I whakaputaina 2017
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: